PMID- 20227863 OWN - NLM STAT- MEDLINE DCOM- 20110719 LR - 20171116 IS - 1590-3729 (Electronic) IS - 0939-4753 (Linking) VI - 21 IP - 4 DP - 2011 Apr TI - Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes. PG - 277-85 LID - 10.1016/j.numecd.2009.12.008 [doi] AB - BACKGROUND AND AIMS: Hyperglycemia and diabetes are associated with increased formation of advanced glycation end products and enhanced oxidative stress, leading to the progression of diabetic vascular disease. We have investigated the mechanisms by which AGE-modified bovine albumin (AGE-BSA) induces reactive oxygen species (ROS) generation, leading to nuclear factor-erythroid 2-related factor (Nrf2) dependent induction of the antioxidant genes heme oxygenase-1 (HO-1) and NADPH:quinone oxidoreductase 1 (NQO1) in bovine aortic endothelial cells. METHODS AND RESULTS: AGE-BSA (100 mug ml(-)(1), 0-24 h), but not native BSA, elicited time-dependent increases in ROS generation, Nrf2 nuclear translocation and enhanced mRNA and protein expression of HO-1 and NQO1, but not glutathione peroxidase-1. Inhibition of ROS production with the superoxide scavenger Tiron or inhibitors of flavoproteins (diphenylene iodonium) and NADPH oxidase (apocynin), but not eNOS (L-NAME) or mitochondria complex I (rotenone) abrogated HO-1 induction by AGE-BSA. Although AGE-BSA induced rapid phosphorylation of JNK and Akt, only inhibition of JNK abrogated HO-1 expression, implicating the involvement of the JNK signaling pathway in AGEs activation of Nrf2/ARE-linked antioxidant gene expression. CONCLUSION: Our findings establish that AGEs activate redox sensitive Nrf2-dependent antioxidant gene expression in bovine aortic endothelial cells, providing an adaptive endogenous defense against oxidative stress in diabetes. CI - Copyright (c) 2010 Elsevier B.V. All rights reserved. FAU - He, M AU - He M AD - Cardiovascular Division, School of Medicine, King's College London, 150 Stamford Street, London SE1 9NH, UK. FAU - Siow, R C M AU - Siow RC FAU - Sugden, D AU - Sugden D FAU - Gao, L AU - Gao L FAU - Cheng, X AU - Cheng X FAU - Mann, G E AU - Mann GE LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100315 PL - Netherlands TA - Nutr Metab Cardiovasc Dis JT - Nutrition, metabolism, and cardiovascular diseases : NMCD JID - 9111474 RN - 0 (Free Radical Scavengers) RN - 0 (Glycation End Products, Advanced) RN - 0 (NF-E2-Related Factor 2) RN - 0 (RNA, Messenger) RN - 0 (Reactive Oxygen Species) RN - 0 (advanced glycation end products-bovine serum albumin) RN - 27432CM55Q (Serum Albumin, Bovine) RN - EC 1.14.14.18 (Heme Oxygenase-1) RN - EC 1.6.5.2 (NAD(P)H Dehydrogenase (Quinone)) SB - IM MH - Animals MH - Cattle MH - Cell Nucleus/drug effects/metabolism MH - Cells, Cultured MH - Diabetes Mellitus/physiopathology MH - Endothelium, Vascular/cytology/drug effects/*metabolism MH - Enzyme Induction/drug effects MH - Free Radical Scavengers/pharmacology MH - Glycation End Products, Advanced/*toxicity MH - Heme Oxygenase-1/*biosynthesis/genetics MH - Hyperglycemia/physiopathology MH - NAD(P)H Dehydrogenase (Quinone)/genetics/metabolism MH - NF-E2-Related Factor 2/agonists/*metabolism MH - *Oxidative Stress MH - Protein Transport/drug effects MH - RNA, Messenger/metabolism MH - Reactive Oxygen Species/*metabolism MH - Serum Albumin, Bovine/*toxicity MH - *Signal Transduction/drug effects MH - Time Factors EDAT- 2010/03/17 06:00 MHDA- 2011/07/20 06:00 CRDT- 2010/03/16 06:00 PHST- 2009/09/16 00:00 [received] PHST- 2009/12/08 00:00 [revised] PHST- 2009/12/16 00:00 [accepted] PHST- 2010/03/16 06:00 [entrez] PHST- 2010/03/17 06:00 [pubmed] PHST- 2011/07/20 06:00 [medline] AID - S0939-4753(09)00317-2 [pii] AID - 10.1016/j.numecd.2009.12.008 [doi] PST - ppublish SO - Nutr Metab Cardiovasc Dis. 2011 Apr;21(4):277-85. doi: 10.1016/j.numecd.2009.12.008. Epub 2010 Mar 15.